Advertisement
Advertisement
SEER
Seer, Inc. Class A Common Stock
1.87
USDSponsored
-0.01
-0.53%
May 08, 16:00 UTC -4
Closed
After-Market
1.87
0.00
0.00%
SEER Earnings Reports
Positive Surprise Ratio
SEER beat 14 of 21 last estimates.
67%
Next Report
In 3 Days
Date of Next Report
May 13, 2026
Estimate for Q1 26 (Revenue/ EPS)
$3.47M
/-$0.28
Implied change from Q4 25 (Revenue/ EPS)
-17.45%
/--
Implied change from Q1 25 (Revenue/ EPS)
-17.53%
/-9.68%
Seer, Inc. Class A Common Stock earnings per share and revenue
On Feb 26, 2026, SEER reported earnings of -0.28 USD per share (EPS) for Q4 25, beating the estimate of -0.32 USD, resulting in a 11.15% surprise. Revenue reached 4.20 million, compared to an expected 4.69 million, with a -10.46% difference. The market reacted with a -17.31% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of -0.28 USD, with revenue projected to reach 3.47 million USD, implying an increase of 0.00% EPS, and decrease of -17.45% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ANI Pharmaceuticals, Inc.
Report Date
May 08, 2026 For Q1 26
Estimate
$1.33
Actual
$2.04
Surprise
+54.04%
Harmony Biosciences Holdings, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.72
Actual
$0.55
Surprise
-24.16%
CytomX Therapeutics, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.10
Surprise
+18.83%
Tectonic Therapeutic, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.20
Actual
-$1.34
Surprise
-11.07%
ALX Oncology Holdings Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.17
Surprise
+24.24%
Entera Bio Ltd. Ordinary Shares
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.07
Surprise
+54.25%
argenx SE - ADR
Report Date
May 07, 2026 For Q1 26
Estimate
$5.47
Actual
$5.52
Surprise
+0.86%
Arrowhead Research Corporation
Report Date
May 07, 2026 For Q2 26
Estimate
-$1.16
Actual
-$0.93
Surprise
+20.32%
ImmunityBio, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.09
Surprise
-26.05%
Stoke Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.84
Actual
-$0.79
Surprise
+6.34%
FAQ
What were Seer, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Seer, Inc. Class A Common Stock reported EPS of -$0.28, beating estimates by 11.15%, and revenue of $4.20M, -10.46% below expectations.
How did the market react to Seer, Inc. Class A Common Stock's Q4 2025 earnings?
The stock price moved down -17.31%, changed from $2.08 before the earnings release to $1.72 the day after.
When is Seer, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for May 13, 2026.
What are the forecasts for Seer, Inc. Class A Common Stock's next earnings report?
Based on 3
analysts, Seer, Inc. Class A Common Stock is expected to report EPS of -$0.28 and revenue of $3.47M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement